Department of Oncology, Faculty of Medicine, University of Calgary, Calgary, AB T2N 4N2, Canada.
Department of Oncology, Faculty of Health Sciences, McMaster University, Hamilton, ON L8V 5C2, Canada.
Curr Oncol. 2022 Mar 2;29(3):1527-1536. doi: 10.3390/curroncol29030128.
The Serious Illness Care Program (SICP), designed by Ariadne Labs, is a multicomponent intervention to improve conversations about values and goals for patients with a life-limiting illness. In oncology, implementation of the SICP achieved more, earlier, and better-quality conversations and reduced anxiety and depression among patients with advanced cancer. In this commentary, we describe the SICP, including results from the cluster-randomized trial, provide examples of real-world implementation of this program, and highlight ongoing challenges and barriers that are preventing widespread adoption of this intervention into routine practice. For the SICP to be successfully embedded into routine patient care, it will require significant effort, including ongoing leadership support and training opportunities, champions from all sectors of the interdisciplinary team, and adaptation of the program to a wider range of patients. Future research should also investigate how early conversations can be translated into personalized care plans for patients.
严重疾病照护计划（SICP）是由阿里阿德涅实验室设计的一项多组分干预措施，旨在改善患有绝症患者的价值观和目标相关对话。在肿瘤学领域，SICP 的实施实现了更多、更早和更高质量的对话，并降低了晚期癌症患者的焦虑和抑郁水平。在这篇评论中，我们描述了 SICP，包括来自集群随机试验的结果，提供了该计划在现实世界中实施的实例，并强调了正在阻碍该干预措施广泛应用于常规实践的持续挑战和障碍。为了使 SICP 成功地融入常规患者护理，需要付出巨大的努力，包括持续的领导力支持和培训机会、跨学科团队各领域的拥护者，以及对该计划进行更广泛的患者适用性调整。未来的研究还应探讨如何将早期对话转化为患者的个性化护理计划。
